I think Labwire would need gross profits (annually) in the ballpark of 100 million to fetch a $2 share price, and probably revenues close to 500 million. Feels like a LONG way off with the current numbers. That's about 1/4 of the total defined market for drug testing. But who knows? Maybe the canines will sell well, too...
Even if I don't see Labwire as large of an opportunity as some, I do think it's at least a safe bet for gradual growth at the current price.
BTW, nice string of summary posts in the Labwire header. Very informative.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.